Li‐Xuan Qin

Phase II Trial of the CDK4 Inhibitor PD0332991 in Patients With Advanced <i>CDK4</i> -Amplified Well-Differentiated or Dedifferentiated Liposarcoma

Mark A. Dickson, William D. Tap, Mary Louise Keohan et al. · Journal of Clinical Oncology · 2013 · 396 citations · Full text

Medicine, Oncology, Pharmacology +16

Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma

Marcus Tan, Murray F. Brennan, Deborah Kuk et al. · Annals of Surgery · 2015 · 366 citations

Medicine, Oncology, Surgery +17

Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With <i>CDK4</i> Inhibitor Palbociclib

Mark A. Dickson, Gary K. Schwartz, Mary Louise Keohan et al. · JAMA Oncology · 2016 · 324 citations · Full text

Medicine, Oncology, Pharmacology +13

Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial

Floris S. Verheij, Dana M. Omer, Hannah Williams et al. · Journal of Clinical Oncology · 2023 · 321 citations · Full text

Medicine, Surgery, Gastrointestinal Oncology +1

Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment

Sandra P. D’Angelo, Alexander N. Shoushtari, Narasimhan P. Agaram et al. · Human Pathology · 2014 · 296 citations · Full text

Medicine, Immunology, Oncology +15